- Home
- MAX vs ARCT Comparison
MAX vs ARCT Comparison
Compare MAX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAX | ARCT |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 657.4M | 293.9M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MAX | ARCT |
|---|---|---|
| Price | $14.53 | $10.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $15.71 | ★ $23.80 |
| AVG Volume (30 Days) | ★ 976.8K | 605.3K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.81 | 20.00 |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $1,113,600,000.00 | $82,031,000.00 |
| Revenue This Year | $21.30 | N/A |
| Revenue Next Year | $11.16 | $64.21 |
| P/E Ratio | $10.70 | ★ N/A |
| Revenue Growth | ★ 28.78 | N/A |
| 52 Week Low | $7.09 | $5.50 |
| 52 Week High | $14.70 | $17.96 |
Technical Indicators
Market Signals| Indicator | MAX | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 75.31 | 43.88 |
| Support Level | $8.39 | $6.53 |
| Resistance Level | N/A | $17.85 |
| Average True Range (ATR) | 0.68 | 0.94 |
| MACD | 0.37 | 0.08 |
| Stochastic Oscillator | 93.84 | 41.67 |
Price Performance
Historical ComparisonAbout MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.